| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,667 | 24,705 | 24,031 | 34,920 | | Cost of Revenue | 15,348 | 13,875 | 13,552 | 19,486 | | | Gross Profit | 12,319 | 10,830 | 10,479 | 15,434 | | | Operating Expenses | | Research Development | 2,865 | 2,855 | 2,898 | 4,108 | | Selling General and Administrative | 8,362 | 8,818 | 9,188 | 9,826 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,092 | (843) | (1,607) | 1,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 166 | (166) |
-
|
-
| | Earnings Before Interest And Taxes | 1,258 | (1,009) | (1,607) | 1,500 | | Interest Expense | 225 | 94 | 227 | 413 | | Income Before Tax | 1,033 | (1,103) | (1,834) | 1,087 | | Income Tax Expense | 106 | 210 | 250 | (762) | | Minority Interest | (25) | (4) |
-
|
-
| | | | Net Income From Continuing Ops | 902 | (1,317) | (2,084) | 1,849 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 902 | (1,317) | (2,084) | 1,849 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $902 | ($1,317) | ($2,084) | $1,849 |
|
0.21% Nasdaq 
Income Statement
